These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 6815063)

  • 1. Controversies in cardiology. Proposed: low-dose aspirin should be taken daily after age 40 if total serum cholesterol is greater than 160.
    Schoenberger JA; Mann GV
    Hosp Pract (Off Ed); 1982 Dec; 17(12):50A, 50D, 50F passim. PubMed ID: 6815063
    [No Abstract]   [Full Text] [Related]  

  • 2. Can aspirin prevent myocardial infarction?
    Med Lett Drugs Ther; 1975 Mar; 17(6):25-6. PubMed ID: 1092992
    [No Abstract]   [Full Text] [Related]  

  • 3. Aspirin, platelets and myocardial infarction--proposal for a trial.
    Williams WO; Elwood PC
    J R Coll Gen Pract; 1975 Nov; 25(160):844. PubMed ID: 772196
    [No Abstract]   [Full Text] [Related]  

  • 4. Usefulness of aspirin for coronary artery disease.
    Fuster V; Cohen M; Chesebro JH
    Am J Cardiol; 1988 Mar; 61(8):637-40. PubMed ID: 3278582
    [No Abstract]   [Full Text] [Related]  

  • 5. Aspirin and ischaemic heart disease.
    Br J Hosp Med; 1986 Aug; 36(2):85. PubMed ID: 3527318
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical trials of platelet-active drugs in coronary heart disease: summary of design features.
    Furberg CD; May GS
    Circulation; 1980 Dec; 62(6 Pt 2):V49-52. PubMed ID: 7002352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of platelet-active drugs in coronary artery disease.
    Sherry S
    Cardiovasc Clin; 1983; 14(1):173-89. PubMed ID: 6352025
    [No Abstract]   [Full Text] [Related]  

  • 8. Reducing the risk: heart disease, stroke and aspirin.
    Elwood PC
    J Med Assoc Thai; 2001 Aug; 84(8):1164-74. PubMed ID: 11758854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Aspirin in patients undergoing percutaneous coronary intervention].
    Güleç S
    Anadolu Kardiyol Derg; 2007 Dec; 7 Suppl 2():9-13. PubMed ID: 18160361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Aspirin and coronary heart disease].
    Dubach P
    Schweiz Rundsch Med Prax; 1988 Sep; 77(37):961-2. PubMed ID: 3175422
    [No Abstract]   [Full Text] [Related]  

  • 11. [Coronary disease: benefits of aspirin. What dose for which disease?].
    Michel PL
    Ann Cardiol Angeiol (Paris); 1994 Apr; 43(4):204-10. PubMed ID: 8024235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of coronary heart disease in practice. Implications of the results of recent clinical trials.
    Borhani NO
    JAMA; 1985 Jul; 254(2):257-62. PubMed ID: 2860255
    [No Abstract]   [Full Text] [Related]  

  • 13. Facts and controversies of aspirin and clopidogrel therapy.
    Faxon DP; Freedman JE
    Am Heart J; 2009 Mar; 157(3):412-22. PubMed ID: 19249409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aspirin to prevent heart attack and stroke: what's the right dose?
    Dalen JE
    Am J Med; 2006 Mar; 119(3):198-202. PubMed ID: 16490462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonsteroidal antiinflammatory drugs and the risk of myocardial infarction in the general population.
    García Rodríguez LA; Varas-Lorenzo C; Maguire A; González-Pérez A
    Circulation; 2004 Jun; 109(24):3000-6. PubMed ID: 15197149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Blood thinning in heart patients].
    Meier B
    Ther Umsch; 1995 Oct; 52(10):661-71. PubMed ID: 7482377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [After the disappointing ASS primary prevention trial. "Holding back in women"].
    Rupprecht HJ
    MMW Fortschr Med; 2005 Mar; 147(12):13. PubMed ID: 15832783
    [No Abstract]   [Full Text] [Related]  

  • 18. Thrombin generation in myocardial infarction and hypercholesterolemia: effects of aspirin.
    Szczeklik A
    Thromb Haemost; 1995 Jul; 74(1):77-80. PubMed ID: 8578530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatable risk factors--hypercholesterolemia, smoking, and hypertension--after myocardial infarction: implications of the coronary drug project data for clinical management. Coronary Drug Project Research Group.
    Prim Care; 1980 Mar; 7(1):175-9. PubMed ID: 6992178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aspirin for prevention of myocardial infarction. A double-edged sword.
    Bar-Dayan Y; Levy Y; Amital H; Shoenfeld Y
    Ann Med Interne (Paris); 1997; 148(6):430-3. PubMed ID: 9538376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.